1425 related articles for article (PubMed ID: 19926003)
1. Appropriate evaluation and treatment of heart failure patients after implantable cardioverter-defibrillator discharge: time to go beyond the initial shock.
Mishkin JD; Saxonhouse SJ; Woo GW; Burkart TA; Miles WM; Conti JB; Schofield RS; Sears SF; Aranda JM
J Am Coll Cardiol; 2009 Nov; 54(22):1993-2000. PubMed ID: 19926003
[TBL] [Abstract][Full Text] [Related]
2. Antiarrhythmic therapy in heart failure.
Eckardt L; Haverkamp W; Breithardt G
Heart Fail Monit; 2002; 2(4):110-9. PubMed ID: 12634885
[TBL] [Abstract][Full Text] [Related]
3. The Midlands Trial of Empirical Amiodarone versus Electrophysiology-guided Interventions and Implantable Cardioverter-defibrillators (MAVERIC): a multi-centre prospective randomised clinical trial on the secondary prevention of sudden cardiac death.
Lau EW; Griffith MJ; Pathmanathan RK; Ng GA; Clune MM; Cooper J; Marshall HJ; Forsey PR; Stafford PJ; Gray RG; Skehan JD; Garratt CJ
Europace; 2004 Jul; 6(4):257-66. PubMed ID: 15172648
[TBL] [Abstract][Full Text] [Related]
4. Implantable cardioverter-defibrillator shocks: epidemiology, outcomes, and therapeutic approaches.
Borne RT; Varosy PD; Masoudi FA
JAMA Intern Med; 2013 May; 173(10):859-65. PubMed ID: 23546173
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of celivarone, with amiodarone as calibrator, in patients with an implantable cardioverter-defibrillator for prevention of implantable cardioverter-defibrillator interventions or death: the ALPHEE study.
Kowey PR; Crijns HJ; Aliot EM; Capucci A; Kulakowski P; Radzik D; Roy D; Connolly SJ; Hohnloser SH;
Circulation; 2011 Dec; 124(24):2649-60. PubMed ID: 22082672
[TBL] [Abstract][Full Text] [Related]
6. [The implantable cardioverter-defibrillator and hypertrophic cardiomyopathy. Experience at three centers].
Marín F; Gimeno JR; Payá E; García-Alberola A; Pérez-Alvarez L; Fernández X; de la Morena G; Sogorb F; Castro-Beiras A; Valdés M; Martínez JG; Monserrat L
Rev Esp Cardiol; 2006 Jun; 59(6):537-44. PubMed ID: 16790196
[TBL] [Abstract][Full Text] [Related]
7. Long-term comparison of the implantable cardioverter defibrillator versus amiodarone: eleven-year follow-up of a subset of patients in the Canadian Implantable Defibrillator Study (CIDS).
Bokhari F; Newman D; Greene M; Korley V; Mangat I; Dorian P
Circulation; 2004 Jul; 110(2):112-6. PubMed ID: 15238454
[TBL] [Abstract][Full Text] [Related]
8. A guide to device selection: cardiac resynchronization therapy alone or in combination with an implantable cardioverter defibrillator.
Prystowsky EN
Rev Cardiovasc Med; 2003; 4 Suppl 2():S47-54. PubMed ID: 12776013
[TBL] [Abstract][Full Text] [Related]
9. Causes and consequences of heart failure after prophylactic implantation of a defibrillator in the multicenter automatic defibrillator implantation trial II.
Goldenberg I; Moss AJ; Hall WJ; McNitt S; Zareba W; Andrews ML; Cannom DS;
Circulation; 2006 Jun; 113(24):2810-7. PubMed ID: 16769917
[TBL] [Abstract][Full Text] [Related]
10. Primary prevention of sudden cardiac death by implantable cardioverter-defibrillator therapy in Chinese patients with heart failure: a single-center experience.
Chen TB; Cheng KA; Gao P; Cheng ZW; Fan JB; Jiang XC; Fang Q
Chin Med J (Engl); 2010 Apr; 123(7):848-51. PubMed ID: 20497676
[TBL] [Abstract][Full Text] [Related]
11. [Biventricular stimulation therapy in patients with heart failure and tachycardic arrhythmias. Indications--results--prospects].
Trappe HJ
Biomed Tech (Berl); 2002 Oct; 47(9-10):243-9. PubMed ID: 12369212
[TBL] [Abstract][Full Text] [Related]
12. Implantable cardioverter defibrillator therapy and the need for concomitant antiarrhythmic drugs.
Singh S; Murawski MM
J Cardiovasc Pharmacol Ther; 2007 Sep; 12(3):175-80. PubMed ID: 17875944
[TBL] [Abstract][Full Text] [Related]
13. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure.
Bardy GH; Lee KL; Mark DB; Poole JE; Packer DL; Boineau R; Domanski M; Troutman C; Anderson J; Johnson G; McNulty SE; Clapp-Channing N; Davidson-Ray LD; Fraulo ES; Fishbein DP; Luceri RM; Ip JH;
N Engl J Med; 2005 Jan; 352(3):225-37. PubMed ID: 15659722
[TBL] [Abstract][Full Text] [Related]
14. Use of beta-blockers in patients with an implantable cardioverter defibrillator.
LaPointe NM; Stafford JA; Pappas PA; Al-Khatib SM; Anstrom KJ
Ann Pharmacother; 2009 Jul; 43(7):1189-96. PubMed ID: 19567655
[TBL] [Abstract][Full Text] [Related]
15. High incidence of appropriate and inappropriate ICD therapies in children and adolescents with implantable cardioverter defibrillator.
Korte T; Köditz H; Niehaus M; Paul T; Tebbenjohanns J
Pacing Clin Electrophysiol; 2004 Jul; 27(7):924-32. PubMed ID: 15271011
[TBL] [Abstract][Full Text] [Related]
16. Role of amiodarone or implantable cardioverter/defibrillator in patients with atrial fibrillation and heart failure.
Singh SN; Poole J; Anderson J; Hellkamp AS; Karasik P; Mark DB; Lee KL; Bardy GH;
Am Heart J; 2006 Nov; 152(5):974.e7-11. PubMed ID: 17070171
[TBL] [Abstract][Full Text] [Related]
17. [The implantable cardioverter/defibrillator (ICD). Developments up to the present time and future perspectives].
Brachmann J; Hilbel T; Schöls W; Beyer T; Schweizer M; Sterns L; Karolyi L; Melichercik J; Freigang KD; Kübler W
Herz; 1994 Oct; 19(5):246-50. PubMed ID: 8001897
[TBL] [Abstract][Full Text] [Related]
18. Predictors for short-term progressive heart failure death in New York Heart Association II patients implanted with a cardioverter defibrillator--the EVADEF study.
Marijon E; Trinquart L; Otmani A; Leclercq C; Fauchier L; Chevalier P; Klug D; Defaye P; Lellouche N; Mansourati J; Deharo JC; Sadoul N; Anselme F; Maury P; Davy JM; Extramiana F; Hidden-Lucet F; Probst V; Bordachar P; Mansour H; Chauvin M; Jouven X; Lavergne T; Chatellier G; Le Heuzey JY;
Am Heart J; 2010 Apr; 159(4):659-664.e1. PubMed ID: 20362726
[TBL] [Abstract][Full Text] [Related]
19. Are implantable cardioverter defibrillator shocks a surrogate for sudden cardiac death in patients with nonischemic cardiomyopathy?
Ellenbogen KA; Levine JH; Berger RD; Daubert JP; Winters SL; Greenstein E; Shalaby A; Schaechter A; Subacius H; Kadish A;
Circulation; 2006 Feb; 113(6):776-82. PubMed ID: 16461817
[TBL] [Abstract][Full Text] [Related]
20. Death without prior appropriate implantable cardioverter-defibrillator therapy: a competing risk study.
Koller MT; Schaer B; Wolbers M; Sticherling C; Bucher HC; Osswald S
Circulation; 2008 Apr; 117(15):1918-26. PubMed ID: 18391108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
